Northwest Bancshares’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-1,119
| Closed | -$316K | – | 176 |
|
|
2025
Q3 | $316K | Buy |
1,119
+32
| +3% | +$9.28K | 0.05% | 150 |
|
|
2025
Q2 | $304K | Buy |
1,087
+3
| +0.3% | +$850 | 0.05% | 153 |
|
|
2025
Q1 | $338K | Sell |
1,084
-13
| -1% | -$3.84K | 0.06% | 145 |
|
|
2024
Q4 | $286K | Sell |
1,097
-273
| -20% | -$81K | 0.05% | 158 |
|
|
2024
Q3 | $441K | Sell |
1,370
-106
| -7% | -$34.7K | 0.08% | 130 |
|
|
2024
Q2 | $461K | Sell |
1,476
-15
| -1% | -$4.41K | 0.08% | 117 |
|
|
2024
Q1 | $424K | Buy |
1,491
+94
| +7% | +$27.5K | 0.07% | 141 |
|
|
2023
Q4 | $402K | Sell |
1,397
-691
| -33% | -$188K | 0.07% | 126 |
|
|
2023
Q3 | $561K | Sell |
2,088
-39
| -2% | -$9.73K | 0.11% | 109 |
|
|
2023
Q2 | $472K | Sell |
2,127
-2,157
| -50% | -$501K | 0.09% | 127 |
|
|
2023
Q1 | $1.04M | Sell |
4,284
-5,708
| -57% | -$1.4M | 0.2% | 83 |
|
|
2022
Q4 | $2.62M | Sell |
9,992
-12,432
| -55% | -$3.33M | 0.53% | 51 |
|
|
2022
Q3 | $5.05M | Sell |
22,424
-251
| -1% | -$60.8K | 1.18% | 22 |
|
|
2022
Q2 | $5.52M | Sell |
22,675
-536
| -2% | -$131K | 1.25% | 17 |
|
|
2022
Q1 | $5.61M | Sell |
23,211
-436
| -2% | -$100K | 1.08% | 22 |
|
|
2021
Q4 | $5.32M | Buy |
23,647
+1,215
| +5% | +$256K | 1.05% | 25 |
|
|
2021
Q3 | $4.77M | Buy |
22,432
+1,153
| +5% | +$265K | 1.09% | 30 |
|
|
2021
Q2 | $5.19M | Buy |
21,279
+833
| +4% | +$205K | 1.18% | 26 |
|
|
2021
Q1 | $5.09M | Buy |
20,446
+891
| +5% | +$213K | 1.2% | 24 |
|
|
2020
Q4 | $4.5M | Buy |
19,555
+2,745
| +16% | +$633K | 1.15% | 25 |
|
|
2020
Q3 | $4.27M | Sell |
16,810
-847
| -5% | -$210K | 1.1% | 21 |
|
|
2020
Q2 | $4.16M | Buy |
17,657
+1,381
| +8% | +$315K | 1.13% | 19 |
|
|
2020
Q1 | $3.3M | Buy |
16,276
+116
| +0.7% | +$25.3K | 1.64% | 17 |
|
|
2019
Q4 | $3.9M | Sell |
16,160
-846
| -5% | -$186K | 1.5% | 17 |
|
|
2019
Q3 | $3.29M | Buy |
17,006
+668
| +4% | +$128K | 1.36% | 23 |
|
|
2019
Q2 | $3.01M | Buy |
16,338
+964
| +6% | +$173K | 1.27% | 23 |
|
|
2019
Q1 | $2.92M | Buy |
15,374
+918
| +6% | +$175K | 1.26% | 25 |
|
|
2018
Q4 | $2.81M | Buy |
14,456
+2,272
| +19% | +$443K | 1.36% | 15 |
|
|
2018
Q3 | $2.53M | Buy |
12,184
+495
| +4% | +$97.6K | 1.12% | 18 |
|
|
2018
Q2 | $2.16M | Buy |
11,689
+58
| +0.5% | +$10.3K | 0.91% | 16 |
|
|
2018
Q1 | $1.98M | Buy |
11,631
+718
| +7% | +$132K | 0.81% | 25 |
|
|
2017
Q4 | $1.9M | Buy |
+10,913
| New | +$1.93M | 0.78% | 27 |
|
Other funds holding AMGN
Northwest Bancshares's AMGN Position: Q4 2025 in Review
Northwest Bancshares sold out of Amgen (AMGN) in Q4 2025, closing a stake of 1,119 shares — an estimated $316K sold.
Northwest Bancshares first reported a position in AMGN in Q4 2017 and held it in 32 quarters. The position peaked at $5.61M in Q1 2022. 3,084 funds tracked by Wall St. Rank hold AMGN as of Q4 2025.
- Northwest Bancshares reported no remaining Amgen position as of Q4 2025 after selling out during the quarter.
- Northwest Bancshares sold 1,119 Amgen shares in Q4 2025, an estimated $316K.
- Northwest Bancshares first reported a position in Amgen in Q4 2017 and held it in 32 quarters.
- Northwest Bancshares's Amgen position peaked at $5.61M in Q1 2022.
- 3,084 funds tracked by Wall St. Rank held Amgen as of Q4 2025.
Based on Northwest Bancshares's 13F filing for Q4 2025, filed 13 Feb 2026.